LAX.SH
SADHANA NITROCHEM LIMITED·CHEMICALS 57.95·Chemicals & Petrochemicals Companies
Price
2.04
-4.68%52W Range
Market Cap
₹618.57 Cr
Traded: ₹1.28 Cr (0.21%) 0.0x
Free Float: ₹210.56 Cr (0.61% of FF traded)
Volume · 60D trend
61.71 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Profit | -- | -- | -- | -- | -1861.0% | -- |
| Sales | +3.0% | -14.0% | -30.0% | -- | -69.0% | Decelerating |
| ROE | +5.0% | -6.0% | -9.0% | -- | -- | Decelerating |
| Return | +33.0% | -16.0% | -46.0% | +77.0% | -- | Stable |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27 | 9 | 10 | 3 | 28 | 49 | 37 | 43 | 36 | 65 | 44 | 42 | 39 | 48 | 31 | 37 |
| Expenses | 25 | 32 | 25 | 20 | 26 | 36 | 26 | 35 | 26 | 55 | 33 | 29 | 32 | 38 | 26 | 32 |
| Operating Profit | 2 | -23 | -15 | -17 | 2 | 13 | 11 | 8 | 10 | 9 | 11 | 13 | 8 | 10 | 5 | 4 |
| Other Income | 4 | 3 | 1 | -0 | 4 | -0 | 0 | 1 | 0 | 2 | 1 | -0 | 1 | 0 | 0 | 0 |
| Interest | 3 | 11 | 7 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 2 | 2 |
| Depreciation | 3 | 4 | 4 | 4 | 5 | 4 | 3 | 4 | 4 | 3 | 4 | 4 | 4 | 3 | 2 | 2 |
| Profit Before Tax | -0 | -34 | -25 | -26 | -2 | 5 | 4 | 1 | 2 | 4 | 4 | 4 | 0 | 3 | 1 | 1 |
| Tax % | 511.1% | -2.1% | 1.7% | -1.7% | -5.4% | 17.5% | 30.6% | 75.0% | 65.2% | 87.5% | 76.6% | 39.0% | 87.2% | 43.0% | 21.0% | 160.0% |
| Net Profit | -1 | -34 | -25 | -26 | -2 | 4 | 3 | 0 | 1 | 1 | 1 | 3 | 0 | 2 | 1 | 0 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 0.0 | -0.1 | -0.1 | -0.1 | -0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 |
| Sales Growth (YoY) | -3.1% | -81.6% | -73.7% | -93.7% | -22.2% | -23.4% | -15.8% | 2.1% | -8.4% | 34.5% | 42.2% | 13.5% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 198.8% | -6.7% | 261.5% | -90.4% | -43.2% | 33.3% | -13.5% | 18.8% | -44.1% | 46.4% | 4.9% | 6.6% | -17.9% | 54.8% | -16.2% | -- |
| OP Growth (YoY) | 19.6% | -272.5% | -235.3% | -305.1% | -79.8% | 42.4% | -1.5% | -33.9% | 22.5% | -7.1% | 128.0% | 213.2% | -- | -- | -- | -- |
| OP Growth (QoQ) | 110.2% | -50.2% | 10.5% | -975.3% | -85.3% | 17.8% | 35.6% | -13.9% | 3.6% | -18.5% | -9.0% | 59.6% | -21.5% | 100.0% | 25.0% | -- |
| Profit Growth (YoY) | -- | -920.0% | -1074.0% | -9927.0% | -442.0% | 688.0% | 177.0% | -90.0% | 933.0% | -70.0% | 24.0% | 795.0% | -94.0% | 175.0% | -54.0% | -123.0% |
| EPS Growth (YoY) | 100.0% | -1200.0% | -900.0% | -- | -- | -- | -- | -100.0% | -- | -100.0% | -- | 200.0% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 100.0% | -37.5% | 11.1% | -800.0% | -200.0% | 0.0% | -- | -- | -- | -- | -100.0% | -- | -100.0% | -- | 100.0% | -- |
| OP Margin | 8.5% | -250.5% | -155.6% | -628.9% | 6.9% | 26.7% | 30.3% | 19.3% | 26.6% | 14.4% | 25.9% | 29.8% | 19.9% | 20.8% | 16.1% | 10.8% |
| Net Margin | -2.0% | -369.1% | -257.6% | -946.3% | -7.5% | 8.3% | 7.0% | 0.6% | 1.7% | 0.8% | 2.1% | 6.1% | 0.1% | 4.2% | 3.2% | 0.0% |
| Material Cost % | -- | 146.0% | 161.0% | 369.0% | 60.0% | 48.0% | 30.0% | 41.0% | 28.0% | 52.0% | 37.0% | 43.0% | 43.0% | 56.0% | 44.0% | 50.0% |
| Employee Cost % | -- | 57.0% | 51.0% | 189.0% | 17.0% | 12.0% | 14.0% | 13.0% | 17.0% | 10.0% | 12.0% | 13.0% | 13.0% | 8.0% | 15.0% | 12.0% |
| P/S | 12.68 | 17.91 | 7.91 | 4.97 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.36 | 1.97 | 2.81 | 2.30 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Sadhana Nitro Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve Sadhana Nitro Chem Limited ....
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 for resignation of Chief Financial Officer
Please find attached Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30 September, 2026
Submission of voting results along with the Scrutinizer Report for the 53rd Annual General Meeting under Regulation 44 of SEBI (LODR) Regulations, 2015
Proceedings of the 53rd Annual General Meeting (AGM) held on Wednesday, September 30, 2026 under regulation 30 of SEBI (LODR), Regulations 2015
Newspaper Advertisement- Notice of the 53rd AGM and E-Voting Information.
Annual Report for FY 2025-26
Notice of 53rd Annual General Meeting
BRSR for FY 2025-26
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niraj Bajaj
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niraj Bajaj
Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith copies of Newspaper Publication of Unaudited Standalone and Consolidated Financial Results for ....
Outcome of Board Meeting held on August 07, 2026
Please find attached Monitoring Agency Report for the quarter ended June 30, 2026.
Statement of Deviation Or Variation for the quarter ended June 30, 2026.
Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
Please find attached Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30 June, 2026.
Closure of Trading Window Intimation
Please find intimation under Regulation 30 of the SEBI (LODR), Regulations, 2015 with respect to Issue and Allotment of 6,75,00,000 Equity Shares having Face Value of Re. 1 each on a preferential ....
Annual Secretarial Compliance Report under regulation 24(A) for FY ended 2025-26
Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith copies of Newspaper publication of Audited Standalone and Consolidated Financial Results for the ....
We wish to inform you that the Company has entered into a long-term supply contract with a Japanese multinational customer for international supply of a speciality chemical product manufactured ....
Outcome of Board Meeting held on May 26, 2026
No Deviation or Variation in the use of proceeds raised through the Right Issue.
Audited Standalone & Consolidated Financial Results for Quarter and Year Ended March 31, 2026
Please find attached Proceedings of the 01/2026-27 Extra-Ordinary General Meeting of the Company held on Friday, May 22, 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure ....
Submission of voting results along with the Scrutinizer Report for the 01/2026-27 Extra Ordinary General Meeting under Regulation 44 of the SEBI (LODR) Regulations, 2015
Sadhana Nitro Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve inter alia: 1. To consider ....
Please find attached Monitoring Agency Report for the quarter ended March 31, 2026.
We are submitting the Corrigendum to the Notice of 01/2026-27 Extra-Ordinary General Meeting of the Company dated 29th April, 2026.
Please find attached clarification letter with respect to your email dated 5th May, 2026 regarding dividend record date of 22.09.2025.
Newspaper Advertisement - Notice of 01/2026-27 Extra-ordinary General Meeting
Please find attached Notice of 01/2026-27 Extra-Ordinary General Meeting (EGM) of the Members of Sadhana Nitro Chem Limited.
Outcome of Board Meeting of the Company held on 29th April, 2026.
Sadhana Nitro Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2026 ,inter alia, to consider and approve 1. To regularise of appointment ....
Please find attached Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31 March, 2026.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Abhishek Javeri
Please find attached herewith the announcement with respect to circular resolution passed by the Board of Directors of the Company.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Asit Javeri
Closure of Trading Window for the quarter ending March 2026
Intimation of Newspaper Publication for Basis of Allotment of Rights Issue
Please find attached Trading Approvals received from BSE and NSE of 263,52,83,328 Equity Shares pursuant to Rights Issue.
Outcome of the meeting of the Right Issue Committee of Sadhana Nitro Chem Limited (the "Company") held on 12th March 2026 at 7.00 P.M
Please find attached herewith the announcement with respect to circular resolution passed by the Board of Directors of the Company.
Please find attached herewith the announcement with respect to change in management of the Company.
Intimation of Newspaper Publication of Rights Issue of Equity Shares.
Intimation of Record Date as per Regulation 42 of the SEBI (LODR) Regulations, 2015 for the purpose of Right Shares.
Outcome of the meeting of the Right Issue Committee of Sadhana Nitro Chem Limited (the "Company") held on 13th February 2026 at 2.00 pm
Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015, please find enclosed herewith the copy of newspaper advertisement of Unaudited standalone and Consolidated Financial Results of ....
Unaudited Financials Results for quarter ended December 31, 2025
Annual Reports
15Credit Ratings
5